Stockscreener 앱 받기
1.87
0.54%
0.01
시간 외 거래:
1.88
0.010
+0.53%
전일 마감가:
$1.86
열려 있는:
$1.81
하루 거래량:
1.12M
Relative Volume:
0.84
시가총액:
$303.75M
수익:
$400.57M
순이익/손실:
$9.21M
주가수익비율:
46.75
EPS:
0.04
순현금흐름:
$146.36M
1주 성능:
+21.43%
1개월 성능:
+20.65%
6개월 성능:
+100.58%
1년 성능:
-55.37%
1일 변동 폭
$1.76
$1.89
1주일 범위
$1.4705
$2.10
52주 변동 폭
$0.5271
$5.1288
아이언우드 제약 Stock (IRWD) Company Profile
명칭
Ironwood Pharmaceuticals Inc
전화
617-621-7722
주소
100 SUMMER STREET, SUITE 2300, BOSTON, MA
IRWD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
1.87 | 302.13M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
124.46 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.56 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.32 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.46 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.33 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
아이언우드 제약 Stock (IRWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-15 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-04-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | 개시 | Leerink Partners | Market Perform |
| 2024-08-08 | 다운그레이드 | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | 개시 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Wells Fargo | Overweight |
| 2023-11-09 | 개시 | Jefferies | Buy |
| 2023-09-28 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-02 | 개시 | CapitalOne | Overweight |
| 2022-04-22 | 개시 | Piper Sandler | Overweight |
| 2020-09-30 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | 개시 | Northland Capital | Outperform |
| 2019-07-10 | 재개 | Credit Suisse | Neutral |
| 2019-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | 업그레이드 | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2018-11-07 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-07-23 | 개시 | H.C. Wainwright | Sell |
| 2018-05-09 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2017-07-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-05-03 | 개시 | Wells Fargo | Outperform |
| 2017-04-07 | 재확인 | Mizuho | Buy |
| 2017-02-22 | 재확인 | Barclays | Equal Weight |
| 2016-11-04 | 재확인 | Mizuho | Buy |
| 2016-10-24 | 재확인 | Wedbush | Neutral |
| 2016-10-10 | 재확인 | Mizuho | Buy |
| 2016-09-27 | 재확인 | WallachBeth | Hold |
모두보기
아이언우드 제약 주식(IRWD)의 최신 뉴스
Live market analysis of Ironwood Pharmaceuticals Inc.July 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com
Can Ironwood Pharmaceuticals Inc. stock continue upward trendJuly 2025 Trade Ideas & Verified Entry Point Detection - newser.com
Will Ironwood Pharmaceuticals Inc. stock maintain dividend yieldJuly 2025 Recap & Safe Capital Growth Stock Tips - newser.com
What’s next for Ironwood Pharmaceuticals Inc. stock price2025 Short Interest & Daily Volume Surge Trade Alerts - newser.com
How Ironwood Pharmaceuticals Inc. (I76) stock trades under stagflation2025 EndofYear Setup & Safe Swing Trade Setups - newser.com
Will Ironwood Pharmaceuticals Inc. stock outperform tech sector in 20252025 Price Action Summary & High Conviction Investment Ideas - newser.com
Can Ironwood Pharmaceuticals Inc. (I76) stock retain market dominanceJuly 2025 Institutional & High Win Rate Trade Tips - newser.com
Ironwood Pharmaceuticals Inc expected to post earnings of 10 cents a shareEarnings Preview - TradingView
Will Ironwood Pharmaceuticals Inc. (I76) stock split increase liquidityForecast Cut & Safe Capital Allocation Plans - newser.com
Price momentum metrics for Ironwood Pharmaceuticals Inc. explained2025 Market Overview & Safe Entry Point Identification - newser.com
Can Ironwood Pharmaceuticals Inc. stock deliver strong Q4 earningsMarket Rally & Advanced Technical Signal Analysis - newser.com
Why Ironwood Pharmaceuticals Inc. (I76) stock could be next leader2025 Volatility Report & Free Expert Verified Stock Movement Alerts - newser.com
Will earnings trigger a reversal in Ironwood Pharmaceuticals Inc.2025 Pullback Review & Reliable Price Breakout Alerts - newser.com
How Ironwood Pharmaceuticals Inc. stock compares to industry benchmarksWeekly Trade Review & AI Driven Price Predictions - newser.com
Is Ironwood Pharmaceuticals Inc. stock a dividend growth opportunity2025 Market Outlook & Free Risk Controlled Daily Trade Plans - newser.com
Will Ironwood Pharmaceuticals Inc. bounce back from current supportInsider Buying & AI Based Buy/Sell Signal Reports - newser.com
Why Ironwood Pharmaceuticals Inc. stock is a must watch in 2025Market Activity Summary & Real-Time Sentiment Analysis - newser.com
Real time breakdown of Ironwood Pharmaceuticals Inc. stock performanceEarnings Risk Summary & Weekly Setup with High ROI Potential - newser.com
Will Ironwood Pharmaceuticals Inc. outperform the marketQuarterly Trade Report & Community Verified Swing Trade Signals - newser.com
What is the fair value of Ironwood Pharmaceuticals Inc. stock now2025 Short Interest & Intraday High Probability Setup Alerts - newser.com
Will breakout in Ironwood Pharmaceuticals Inc. lead to full recovery2025 Market Sentiment & Free Community Supported Trade Ideas - newser.com
Is it time to cut losses on Ironwood Pharmaceuticals Inc.Analyst Upgrade & High Accuracy Swing Trade Signals - newser.com
Pattern recognition hints at Ironwood Pharmaceuticals Inc. upsideQuarterly Earnings Report & Safe Capital Growth Tips - newser.com
Published on: 2025-11-02 02:58:49 - newser.com
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Held Back By Insufficient Growth Even After Shares Climb 32% - 富途牛牛
Published on: 2025-11-01 04:03:50 - newser.com
Ironwood Pharmaceuticals (IRWD) Surges 28% on Strong Linzess Sal - GuruFocus
Ironwood surges 28% as beneficiary of partner AbbVie's Linzess Q3 sales (IRWD:NASDAQ) - Seeking Alpha
Ironwood Pharmaceuticals (IRWD) Expected to Announce Earnings on Thursday - MarketBeat
Quantitative breakdown of Ironwood Pharmaceuticals Inc. recent moveMarket Growth Report & Pattern Based Trade Signal System - newser.com
아이언우드 제약 (IRWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
아이언우드 제약 주식 (IRWD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| John Minardo | Chief Legal Officer |
Aug 11 '25 |
Sale |
0.84 |
7,754 |
6,513 |
400,378 |
| Martini Gregory S. | Chief Financial Officer |
Aug 11 '25 |
Sale |
0.84 |
1,265 |
1,063 |
182,545 |
| Silver Ronald | Principal Accounting Officer |
Aug 11 '25 |
Sale |
0.84 |
2,846 |
2,391 |
276,809 |
3.60%
0.45%
자본화:
|
볼륨(24시간):